Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14380300Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$5.2M
Full award amounts, FY2025
Award Records
15
Records listing this PI
Award-Linked Rank
#1,288
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $5.2M in linked award amounts across 15 award records · Award-linked rank #1288.
FY2025 award records by amount
NIH award records listing Juan Marugan as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000209-11ZIASmall molecule agonists of the relaxin 1 receptor$418.4Kaward amount
- 1ZIATR000212-11ZIADiscovery of Novel Modulators of the Human D2 Dopamine Receptor$418.4Kaward amount
- 1ZIATR000203-11ZIAHTS to Identify Inhibitors of c-Abl kinase for the Potential Treatment of Epilepsy and Neurodegenerative diseases$418.4Kaward amount
- 1ZIATR000208-11ZIAProgression of Metarrestin that Reduces PNC Prevalence and Elucidation of its Mechanism of Action$418.4Kaward amount
- 1ZIATR000267-10ZIAMedicinal chemistry campaign to synthesize synaptamide analogs (GPR110)$418.4Kaward amount
- 1ZIATR000302-09ZIACD206 activators as novel immunomodulators$418.4Kaward amount
- 1ZIATR000432-05ZIAEvaluation of cAbl allosteric inhibitors in Gaucher-Parkinson$418.4Kaward amount
- 1ZIATR000083-11ZIAIdentification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction$418.4Kaward amount
- 1ZIATR000086-11ZIAIdentification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent$418.4Kaward amount
- 1ZIATR000096-11ZIAPAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress$418.4Kaward amount
+5 more grants not shown.
Award organization
Organizations that administered FY2025 awards listing Juan Marugan as a PI.
FY2025 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardNational Center for Advancing Translational Sciences
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025$5M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #1288
- 2025Entered Top 25% NationallyRanked #1288
- 2025Entered Top 10% NationallyRanked #1288